Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ILOPROST TROMETHAMINE for Systemic scleroderma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where ILOPROST TROMETHAMINE was used for Systemic scleroderma.

Most Reported Side Effects for ILOPROST TROMETHAMINE

Side Effect Reports % Deaths Hosp.
Off label use 11 15.5% 2 4
Right ventricular failure 11 15.5% 10 6
Encephalopathy 8 11.3% 0 8
Congestive cardiomyopathy 7 9.9% 0 0
Disease progression 7 9.9% 6 6
Sepsis 7 9.9% 6 6
Drug ineffective 6 8.5% 5 0
Pneumonia 6 8.5% 5 6
Cardiac dysfunction 5 7.0% 5 5
Galectin-3 increased 5 7.0% 5 5
Left ventricular dysfunction 5 7.0% 5 5
Multiple organ dysfunction syndrome 5 7.0% 5 5
Myocardial fibrosis 5 7.0% 5 5
Myocarditis 5 7.0% 5 5
Respiratory failure 5 7.0% 5 5

Other Indications for ILOPROST TROMETHAMINE

Pulmonary arterial hypertension (12) Peripheral arterial occlusive disease (8) Peripheral ischaemia (8) Osteonecrosis (7) Raynaud's phenomenon (5)

Other Drugs Used for Systemic scleroderma

RITUXIMAB (554) MYCOPHENOLATE MOFETIL (474) TOCILIZUMAB (332) METHOTREXATE (307) NINTEDANIB (204) PREDNISOLONE (156) CYCLOPHOSPHAMIDE (142) PREDNISONE (128) BOSENTAN (120) IMATINIB (118)

Related Pages

ILOPROST TROMETHAMINE Full Profile All Systemic scleroderma Drugs ILOPROST TROMETHAMINE Demographics ILOPROST TROMETHAMINE Timeline